BioSkepsis vs Elicit — A Biomedical-Native Alternative
Elicit is a strong generalist research assistant. BioSkepsis is purpose-built for biology, medicine, and life-science research. Here is how the two differ, in neutral terms, with sources.
At a glance
| Feature | BioSkepsis | Elicit |
|---|---|---|
| Domain focus | Biomedical & life-science native | General science, all academic fields |
| Paper corpus | 40M+ curated biomedical papers | 138M papers + 545K clinical trials |
| Retrieval model | Biology-native knowledge graph (Gene Ontology + MeSH + genes) | Semantic similarity over academic corpus |
| Full-text reasoning | Yes — analyses methods, controls, supplementary | Full-text analysis on higher tiers (Pro) |
| Structured data extraction tables | Mechanistic-links table (Plus+) | Column extraction across papers (flagship) |
| Systematic review workflow | Research landscape + smart select | Guided flow (search → screen → extract → report) |
| Lab-result interpretation | Upload notes → mapped against literature | Not a primary feature |
| Free tier | Yes — ongoing free access | Yes — with caps (see vendor pricing) |
| Zotero / reference-manager sync | Yes | Yes |
Free tier availability
Both tools offer a free tier. We deliberately do not print dollar amounts here because vendor pricing changes; always verify on the live pricing page.
- BioSkepsis — free tier: yes
- Basic tier includes semantic search, landscape graph, and hypothesis/methodology generation with a cap of 100 papers per session. Ongoing, no time limit. BioSkepsis pricing →
- Elicit — free tier: yes (capped)
- Time-limited credits and capped reports per month. See vendor page for current terms. Elicit pricing →
When to choose which
BioSkepsisYou work in biology, medicine, pharma, biotech, or ag/vet/env science
BioSkepsis was built for life-science literature specifically. Retrieval is weighted by Gene Ontology terms, MeSH descriptors, gene symbols, and pathway relationships — so searches return biologically relevant papers, not just text-similar ones. Elicit covers all disciplines and treats biomedical papers the same as education or economics papers.
ElicitYou need structured data extraction across 50+ papers with custom columns
Elicit's column-extraction workflow (sample size, intervention, effect size, limitations) is its flagship feature and is more mature than BioSkepsis's mechanistic-links table. If your workflow is "I have 50 RCTs and I need a spreadsheet of their endpoints," Elicit is the right tool today.
BioSkepsisYou want to upload your own experimental notes and get literature interpretation
BioSkepsis lets you paste lab results or describe an experiment and maps it against published evidence to explain where findings align or conflict. Elicit does not offer a comparable lab-result interpretation workflow.
ElicitYou need a generalist tool for an interdisciplinary review
If you are reviewing literature across education, economics, policy, and public health at once, Elicit's broader corpus will surface relevant papers that a biomedical-focused tool will not index.
BioSkepsisYou want ongoing free access rather than a fixed credit pool
BioSkepsis Basic is free with ongoing usage (100 papers per session). Elicit Basic provides one-time credits and capped reports per month. See each vendor's live pricing page for current paid-tier terms.
Frequently asked questions
Is BioSkepsis a drop-in replacement for Elicit?
Not quite — the two tools overlap but optimise for different jobs. BioSkepsis is biomedical-native with a biology knowledge graph (Gene Ontology + MeSH) and lab-result interpretation. Elicit is a generalist research assistant with a mature column-extraction workflow. Many researchers use both: BioSkepsis for biomedical discovery and mechanistic reasoning, Elicit for structured multi-paper data extraction.
Does BioSkepsis cover clinical trials like Elicit does?
BioSkepsis indexes clinical trials, case reports, meta-analyses, and randomised controlled trials as part of its 40M+ biomedical corpus. Elicit has dedicated ClinicalTrials.gov integration covering hundreds of thousands of trials. If systematic RCT discovery is your only job, Elicit's trial-specific indexing is more direct.
How does BioSkepsis handle hallucinations compared to Elicit?
Both tools ground answers in retrieved papers and provide citations. BioSkepsis limits reasoning to citable peer-reviewed sources and your own uploaded notes, and explicitly declines to answer when evidence is insufficient. Elicit similarly provides citations for every claim. Neither tool invents sources. Users should still verify cited passages on both platforms before relying on claims in publications.
Is BioSkepsis cheaper than Elicit?
At comparable-capacity tiers, BioSkepsis has historically been priced below Elicit. Because both vendors update their pricing, we do not list dollar amounts here — check each vendor's live pricing page for current terms. Note that BioSkepsis Basic is an ongoing free tier, whereas Elicit's free tier provides a fixed pool of one-time credits.
Can I use both BioSkepsis and Elicit together?
Yes, and many researchers do. A common pattern: start in BioSkepsis to explore a biological question using the knowledge graph and landscape view, then switch to Elicit when you need to extract structured tabular data across a fixed set of papers.
Does BioSkepsis integrate with Zotero?
Yes. BioSkepsis supports direct export to Zotero and other reference managers, matching Elicit's export functionality.
Try BioSkepsis free — no credit card
Biology-native knowledge graph across 40M+ biomedical papers. Free tier with 100 papers per session, Zotero sync, full-text reasoning.
Start freeSources & further reading
- Elicit official pricing
- Elicit plans overview (support)
- Paperguide: Elicit vs SciSpace
- HKUST Library: Trust in AI evaluation